United States: Long COVID has become a threat, and the health experts have been addressing the related concerns for a long time now. Recently, it has been revealed that the COVID-19 vaccines linked boosters have been contributing towards 25 percent lower odds of the infection.

Reportedly, a recently published study in Vaccine of US, the adults who have received the booster dose have 25 percent less chances as compared to the people who are unvaccinated, as reported by cidrap.umn.edu.

In a study centered on 8,757 participants of the 2022 National Health Interview Survey, data were gathered from a weighted cohort comprising 87,509,670 individuals in the United States.

The researchers utilized self-disclosed COVID-19 booster vaccination status and self-reported instances of prolonged COVID-19 symptoms (defined as the persistence of new or ongoing symptoms for a duration of 3 months or more subsequent to an initial COVID-19 infection) to compute odds ratios (ORs) pertaining to the development of protracted COVID-19.

A quintile of respondents disclosed that they had been enduring long COVID, as cidrap.umn.edu mentioned.

At large, 22.2% (19,396,656) remained unvaccinated against COVID-19, 17.3% (15,151,843) had received a single dose of the COVID-19 vaccine, 33.3% (29,184,366) had completed the primary series of COVID-19 vaccination, and 27.2% (23,776,806) had undergone administration of the COVID-19 booster vaccine. Within the respondent pool, 19.5% recounted the occurrence of long COVID (17,102,276).

The findings of this pilot study corroborated that among those who underwent the booster COVID-19 vaccine, they demonstrated astonishingly lower adjusted odds of suffering long-term COVID (OR 0.75, with the 95% CI being 0.61 to 0.93) compared to those who were not vaccinated.

“Our discoveries intimate that ensuring individuals remain current with their COVID-19 vaccinations could serve as an efficacious strategy in the domain of public health for curtailing the prevalence of long-COVID,” concluded the authors.